Clinical trials market in India has performed outstandingly well over
the past few years, according to a new report by Research and Markets.
The country started to exploit opportunities in clinical research a few
years ago; and now the market is attracting Indian and foreign
companies. Although the market is in its nascent stage, it is the
foreign investments that have attracted the attention of several Indian
corporates, and encouraged them to venture into the sector.

The report titled, India Clinical Trial Market: An Emerging Opportunity
for Healthcare Players, states that with over one billion population
and 15,000 hospitals; India can offer a lot more to pharma and clinical
research companies; and investments at this point of time can get great
returns.

Ecron Acunova opens new center
Ecron Acunova, a leading clinical research organization in India, has
launched its second facility, Functional Services Center, in Bangalore.
The center was dedicated by Prof Jagdish Sheth, leading thinker on
marketing and strategy from Emory University, Atlanta, US. This
development center is part of growth plans of the company in the area
of medical and pharmacovigilance services. The launch will broaden
Ecron Acunova’s offering in drug safety services.

The center will employ 60 people initially, and will scale up to 200
people, over the next two years. The center is fully-compliant with 21
CFR part 11 regulations; and is equipped with tools like Oracle
ClinicalT, Remote Data Capture, SAST, WHO-DD, MedDRA, nQuery Advisor,
Winonlin, ARK and Oracle Adverse Event reporting system, for enhancing
reliability and reproducibility.